Who Exports Calcium from India — 996 Suppliers Behind a $895.2M Market
India's calcium export market is supplied by 996 active exporters who collectively shipped $895.2M across 15,000 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 28.1% market share, followed by MYLAN LABORATORIES LIMITED and PIRAMAL PHARMA LIMITED. The top 5 suppliers together control 74.6% of total export value, reflecting a concentrated market structure.
Top Calcium Exporters from India — Ranked by Export Value
INTAS PHARMACEUTICALS LIMITED is the leading calcium exporter from India, holding a 28.1% share of the $895.2M market across 15,000 shipments from 996 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, PIRAMAL PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, BIOCON PHARMA LIMITED — collectively control 74.6% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (28.1%), MYLAN LABORATORIES LIMITED (17.7%), PIRAMAL PHARMA LIMITED (16.3%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (6.4%), BIOCON PHARMA LIMITED (6.1%).
Top Calcium Exporters from India
Ranked by export value · 996 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED PH.DRU.& MED.: ACH-ATORVASTATIN 20MG TABLETS [8315X1X500T]PH.DRU.& MED.: ACH-ATORVASTATIN 40MG TABLETS [2122X1X500T] | $251.6M | 9 | 28.1% |
| 2 | MYLAN LABORATORIES LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKSCROSSCAL TABLETS (CALCIUM 500 MG AND VIT | $158.4M | 4 | 17.7% |
| 3 | PIRAMAL PHARMA LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKS | $146.4M | 1 | 16.3% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSPH.DRU.& MED.: ACH-ATORVASTATIN 20MG TABLETS [8315X1X500T]ATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKS | $57.0M | 22 | 6.4% |
| 5 | BIOCON PHARMA LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKSOTHER-ROSUCOR 10 MG TABLETS NOS SIZE 3 X 10 TABLETS | $54.6M | 4 | 6.1% |
| 6 | UMEDICA LABORATORIES PRIVATE LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSPH.DRU.& MED.: ACH-ATORVASTATIN 20MG TABLETS [8315X1X500T]ATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKS | $36.2M | 5 | 4.0% |
| 7 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKS | $25.0M | 1 | 2.8% |
| 8 | CIPLA LIMITED SOFLAX TABLETS [PAC SIZE:3X20X17820 PAC= 1069200 NOS]SENADE TABATORVA 10 TAB 10X10 TABLETS | $13.9M | 15 | 1.5% |
| 9 | ZYDUS LIFESCIENCES LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSPH.DRU.& MED.: ACH-ATORVASTATIN 20MG TABLETS [8315X1X500T]ATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKS | $12.7M | 11 | 1.4% |
| 10 | ANNORA PHARMA PRIVATE LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKS | $10.0M | 1 | 1.1% |
| 11 | MSN LABORATORIES PRIVATE LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKS | $8.8M | 7 | 1.0% |
| 12 | TORRENT PHARMACEUTICALS LTD ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKSOTHER-ROSUCOR 10 MG TABLETS NOS SIZE 3 X 10 TABLETS | $8.4M | 14 | 0.9% |
| 13 | SUVEN PHARMACEUTICALS LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKS | $5.4M | 1 | 0.6% |
| 14 | HETERO LABS LIMITED ATORVASTATIN CALCIUM TABLETS USP 40 MG 500BT 13536 PACKSATORVASTATIN CALCIUM TABLETS USP 80 MG 90BT 61483 PACKSLUSTATIN 10 | $5.1M | 9 | 0.6% |
| 15 | PANACEA BIOTEC PHARMA LIMITED SENADE TAB | $5.0M | 1 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Calcium exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Intas Pharmaceuticals Limited | Warning Letter, November | Yes, April 2007 | Yes | Not verified | Received FDA Warning Letter in November 2023; WHO-GMP certified in April 2007; E |
| Mylan Laboratories Limited | Warning Letter, December | Yes, March 2025 | Unknown | Not verified | Received FDA Warning Letter in December 2024; WHO-GMP certified in March 2025. |
| Piramal Pharma Limited | Approved | Unknown | Unknown | Multiple | Holds multiple FDA approvals; no warning letters found. |
| Sun Pharmaceutical Industries Limited | Approved | Unknown | Unknown | Multiple | Holds multiple FDA approvals; no warning letters found. |
| Cipla Limited | Warning Letter, November | Unknown | Unknown | Not verified | Received FDA Warning Letter in November 2023. |
| Zydus Lifesciences Limited | Approved | Unknown | Unknown | Multiple | Holds multiple FDA approvals; no warning letters found. |
| Torrent Pharmaceuticals Ltd | Warning Letter, October 2 | Unknown | Unknown | Not verified | Received FDA Warning Letter in October 2019. |
| Hetero Labs Limited | Approved | Unknown | Unknown | Multiple | Holds multiple FDA approvals; no warning letters found. |
TransData Nexus reviewed the regulatory standing of 8 leading Calcium exporters from India. 4 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 1 are EU GMP compliant. 4 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Calcium sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a pivotal hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of Active Pharmaceutical Ingredients (APIs) and bulk drugs. This robust infrastructure positions Hyderabad as a key player in the calcium-based pharmaceutical sector, ensuring a steady supply of high-quality APIs for both domestic and international markets.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to leading companies such as Intas Pharmaceuticals Limited and Piramal Pharma Limited, which are among the top exporters of calcium-based pharmaceutical products. The presence of these industry leaders underscores the region's capacity for producing high-quality formulations, catering to a diverse global clientele.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for pharmaceutical products. With well-established ports like Nhava Sheva (Jawaharlal Nehru Port), this region facilitates efficient international distribution. Companies such as Sun Pharmaceutical Industries Limited and Cipla Limited leverage this strategic location to export calcium-based pharmaceuticals to major markets, including the United States and Canada.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives. This area attracts numerous pharmaceutical companies, contributing to the production of various formulations, including those containing calcium. The tax benefits and supportive infrastructure make Baddi-Nalagarh an attractive destination for pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: While major exporters like Intas Pharmaceuticals and Mylan Laboratories dominate the market, consider engaging with emerging suppliers in regions like Baddi-Nalagarh to mitigate supply chain risks.
- Leverage Export Hubs: Utilize the logistical advantages of export gateways such as Mumbai to streamline international shipments and reduce lead times.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international quality standards and possess necessary certifications from regulatory bodies like the USFDA and EU-GMP.
- Assess Infrastructure Capabilities: Evaluate the manufacturing infrastructure of potential suppliers, particularly in established clusters like Hyderabad and Ahmedabad-Vadodara, to ensure consistent product quality and supply reliability.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Calcium exporters from India
Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals
Sun Pharma entered into a definitive merger agreement to acquire the remaining stake in Taro Pharmaceuticals for $347.73 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's product portfolio, potentially increasing its calcium-based product exports.
Impact: This acquisition is expected to enhance Sun Pharma's product portfolio, potentially increasing its calcium-based product exports.
Common Questions — Calcium Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which calcium supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 57 recorded shipments worth $251.6M. MYLAN LABORATORIES LIMITED (264 shipments) and PIRAMAL PHARMA LIMITED (289 shipments) are also established high-volume exporters.
Q How many calcium manufacturers are there in India?
India has 996 active calcium exporters with a combined export market of $895.2M across 15,000 shipments to 184 countries. The top 5 suppliers hold 74.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for calcium from India?
Average FOB unit price: $7.51 per unit, ranging from $0.00 to $3758.52. Average shipment value: $59.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 996 verified Indian exporters of Calcium ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 184 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
996 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists